Equities

Kilitch Drugs (India) Ltd

KILITCH:NSI

Kilitch Drugs (India) Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)367.45
  • Today's Change-2.55 / -0.69%
  • Shares traded25.65k
  • 1 Year change+62.59%
  • Beta0.9489
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income19412096
Depreciation/depletion333625
Non-Cash items856214
Cash taxes paid, supplemental704325
Cash interest paid, supplemental59----
Changes in working capital(313)(192)(77)
Total cash from operations(1.46)2658
INVESTING
Capital expenditures(65)(38)(82)
Other investing and cash flow items, total(31)117(70)
Total cash from investing(95)79(153)
FINANCING
Financing cash flow items(45)(50)56
Total cash dividends paid----(12)
Issuance (retirement) of stock, net39250.88
Issuance (retirement) of debt, net951825
Total cash from financing88(7.16)70
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash(8.84)98(24)
Net cash-begin balance/reserved for future use198101125
Net cash-end balance/reserved for future use190198101
SUPPLEMENTAL INCOME
Depreciation, supplemental333625
Cash interest paid, supplemental59----
Cash taxes paid, supplemental704325
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.